FGF20 and Parkinson disease: Tarale et al. (2018) proposed hsa-miR-433-3p that bound to FGF20 mRNA transcripts negatively regulated FGF20 protein translation. Their study explored the regulatory relationship between hsa-miR-433-3p and FGF20, which might be potentially useful for PD diagnosis and treatment. The expression of hsa-miR-433-3p was also significantly decreased in SH-SY5Y cells. Tarale et al. demonstrated that FGF20 was a target of hsa-miR-433-3p with an inverse correlation in expression levels (Tarale et al., 2018).